These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 65846)
1. [General mechanisms of biochemical regulation of the kallikrein, clotting and fibrinolytic systems of the blood]. Gomazkov OA; Komissarova NV Usp Sovrem Biol; 1976; 82(6):356-70. PubMed ID: 65846 [No Abstract] [Full Text] [Related]
2. Components of the kallikrein-kinin-system in patients with ARDS. Fuhrer G; Heller W; Junginger W; Gröber O; Roth K Prog Clin Biol Res; 1989; 308():737-42. PubMed ID: 2476827 [No Abstract] [Full Text] [Related]
3. Effector mechanisms and products of the physiological fibrinolytic systems. Edgington TS; Plow EF Prog Clin Biol Res; 1976; 5():85-120. PubMed ID: 61595 [No Abstract] [Full Text] [Related]
4. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation. Kaplan AP; Meier HL; Mandle R Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682 [No Abstract] [Full Text] [Related]
5. Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities. Patrassi GM; Martinelli S; Vianello C; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(4):644-54. PubMed ID: 6184289 [TBL] [Abstract][Full Text] [Related]
6. The kinin system: its relation to blood coagulation, fibrinolysis and the formed elements of the blood. Movat HZ Rev Physiol Biochem Pharmacol; 1978; 84():143-202. PubMed ID: 152965 [No Abstract] [Full Text] [Related]
7. Surface-mediated reactions of blood clotting and related phenomena. Ratnoff OD Nouv Rev Fr Hematol (1978); 1979; 21(1):75-9. PubMed ID: 158745 [No Abstract] [Full Text] [Related]
8. The Hageman factor dependent pathways of human plasma. Kaplan AP Microvasc Res; 1974 Jul; 8(1):97-111. PubMed ID: 4278345 [No Abstract] [Full Text] [Related]
9. Effects of alpha 2-macroglobulin on DIC. Igarashi M; Takatsuka J; Asada T Nihon Ketsueki Gakkai Zasshi; 1978 Dec; 41(6):1118-22. PubMed ID: 87100 [No Abstract] [Full Text] [Related]
11. Interrelationships of the fibrinolytic, coagulation, kinin generating and complement systems. Schreiber AD; Austen KF Ser Haematol; 1973; 6(4):593-600. PubMed ID: 4212102 [No Abstract] [Full Text] [Related]
12. Soluble mediators of injury of the microvasculature; Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems. Cochrane CG; Revak SD; Wuepper KD; Johnston A; Morrison DC; Ulevitch R Microvasc Res; 1974 Jul; 8(1):112-21. PubMed ID: 4278273 [No Abstract] [Full Text] [Related]
13. Chemistry of the hemostatic mechanism and its relationship to the action of heparin. Rosenberg RD Fed Proc; 1977 Jan; 36(1):10-8. PubMed ID: 63388 [No Abstract] [Full Text] [Related]
14. Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein. Ogston D; Bennett B Br Med Bull; 1978 May; 34(2):107-12. PubMed ID: 148934 [No Abstract] [Full Text] [Related]
15. [Factor XII (HAGEMAN FACTOR)]. Kase F; Klír P; Pospísil J; Poucková P Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):1-19. PubMed ID: 77809 [TBL] [Abstract][Full Text] [Related]
16. The differentiation of esterase and fibrinolytic activity in human plasma euglobulin preparations. Harpel P Thromb Diath Haemorrh; 1968 Jul; 19(3):596-8. PubMed ID: 4236827 [No Abstract] [Full Text] [Related]
17. Possible physiological role of new peptide fragments released from bovine high molecular weight kininogen by plasma kallikrein. Oh-ishi S; Katori M; Nam Han Y; Iwanaga S; Kato H Biochem Pharmacol; 1977 Jan; 26(2):115-20. PubMed ID: 138423 [No Abstract] [Full Text] [Related]
18. Studies on components of the plasma kallikrein system as a risk factor in diabetics undergoing cardiopulmonary bypass. Heller W; Gallimore MJ; Hoffmeister HE Agents Actions Suppl; 1992; 38 ( Pt 3)():311-6. PubMed ID: 1281380 [TBL] [Abstract][Full Text] [Related]